Wednesday, January 18, 2023 5:28:30 AM
That’s good all it takes is just basic information to get out to the public and people will understand how deceptive Pfizer was with even basic information. Gonna be a long process but hopefully it will follow the money and bring some much needed justice. Unbelievable what has been done, there’s going to be so many millions of outraged people it will be extremely difficult for those responsible to escape justice.
Recent PFE News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/10/2026 05:10:35 PM
- Pfizer Invites Shareholders to View and Listen to Webcast of April 23 Virtual 2026 Annual Meeting of Shareholders • Business Wire • 04/09/2026 02:00:00 PM
- Telix Strengthens Board with Additional Director Appointments • GlobeNewswire Inc. • 04/08/2026 10:44:20 PM
- AI-Enhanced Robotics in Pharma Manufacturing Signals Major Efficiency, Margin Expansion Opportunities • GlobeNewswire Inc. • 04/07/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 09:52:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 12:22:26 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 12:21:25 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 12:20:23 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 12:19:22 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 12:19:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 12:18:19 AM
- Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts • Business Wire • 03/24/2026 02:00:00 PM
- Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial • Business Wire • 03/23/2026 10:45:00 AM
- Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC • Business Wire • 03/20/2026 08:30:00 PM
- Pfizer’s TALZENNA combination shows progress against prostate cancer • IH Market News • 03/19/2026 02:44:13 PM
- TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer • Business Wire • 03/19/2026 10:45:00 AM
- Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer • Business Wire • 03/17/2026 10:45:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/16/2026 09:45:46 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/12/2026 01:12:24 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/12/2026 01:05:18 PM
- Pfizer shares slip despite encouraging trial results for eczema treatment • IH Market News • 03/09/2026 01:52:10 PM
- Pfizer’s Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis • Business Wire • 03/09/2026 10:45:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 10:27:54 PM
